Clinical Trials Browser

Disease Progression × Interleukin-2 × Other solid neoplasm × Clear all

NCT03546426 2024-10-01

MESOVAX

Phase 1 Active not recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Disease Progression